NCT03193307View on ClinicalTrials.gov

This Study Tests in Healthy Korean Women Which Effects BI 409306 and a Birth-control Pill Have on Each Other

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 29, 2017

Primary Completion Date

December 1, 2017

Study Completion Date

December 1, 2017

Conditions
Healthy
Interventions
DRUG

Microgynon® 30

Run in period \& Treatment Period

DRUG

BI 409306

Day 18 \& 29 (Treatment Period)

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY